Tenax Therapeutics, Inc. Gains 297.44%
Tenax Therapeutics, Inc. (TENX:NASDAQ) jumped higher at $0.62, representing a gain of 297.4%. On Mon, Nov 13, 2023, TENX:NASDAQ touched a New 2-Week High of $0.62. The stock got featured on our News Catalysts scanner on Mon, Nov 13, 2023 at 12:53 PM in the 'BIOTECH' category. From Mon, Oct 30, 2023, the stock recorded 20.00% Up Days and 9.09% Green Days
About Tenax Therapeutics, Inc. (TENX:NASDAQ)
Tenax Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing & commercializing pharmaceutical products for critical care patients and its products include Levosimendan & Oxycyte.
Top 10 Gainers:
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 297.44%
- Viveve Medical, Inc. (VIVE:NASDAQ), 81.82%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 78.33%
- Heliogen Inc. (HLGN:NYSE), 49.92%
- Enviva Partners, LP (EVA:NYSE), 49.51%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 40.27%
- The Singing Machine Company Inc. (MICS:NASDAQ), 36.92%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 36%
- Montauk Renewables Inc. (MNTK:NASDAQ), 34.39%
- reAlpha Tech Corp. (AIRE:NASDAQ), 33.86%